Spectrum Pharmaceuticals reported $57.27M in Current Liabilities for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Actinium Pharmaceuticals ATNM:US $ 4.19M 317K
Agios Pharmaceuticals AGIO:US $ 57.9M 2.75M
Alnylam Pharmaceuticals ALNY:US $ 610.66M 56.01M
Amgen AMGN:US $ 14842M 257M
Arrowhead Research ARWR:US $ 146.54M 48.9M
Astellas Pharma 4503:JP Y 554768M 26812M
AstraZeneca AZN:LN 23649M 1427M
Bayer BAYN:GR € 28727M 801M
Biogen BIIB:US $ 4211.6M 864.4M
Bristol Myers Squibb BMY:US $ 21460M 2469M
Coherus Biosciences CHRS:US $ 320.35M 33.3M
Eli Lilly And LLY:US $ 13682M 1411.2M
Endo International Ordinary Shares ENDP:US $ 1554.27M 145.06M
GlaxoSmithKline GSK:LN 22417M 1030M
Karyopharm Therapeutics KPTI:US $ 68.87M 10.74M
Mirati Therapeutics MRTX:US $ 122.08M 58.79M
Novartis NOVN:VX SF 29880M 247M
Puma Biotechnology PBYI:US $ 116.26M 21.64M
Seattle Genetics SGEN:US $ 698.43M 264.6M
Spectrum Pharmaceuticals SPPI:US $ 57.27M 0.57M
Takeda 4502:JP Y 1918750M 273984M
Teva Pharmaceutical TEVA:IT 11.82B 866M
YTE INCY:US $ 742.71M 82.39M